Evidence map›Paper›PMID 24392454›Full record

ArticleBioMed research international2013

Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98.

Zigui Chen, Quan Cheng, Zhiming Ma, Haipeng Xi, Renjun Peng, Bing Jiang

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. The biological complexity of RKIP signaling in human cancers.Experimental & molecular medicine · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zigui ChenDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Quan ChengDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Zhiming MaDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Haipeng XiDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Renjun PengDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Bing JiangDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Raf-1 kinase inhibitor protein (RKIP) is a tumor and metastasis suppressor in cancer cells. MicroRNAs (miRNAs) have been suggested to play a vital role in tumor initiation and progression by negatively regulating oncogenes and tumor suppressors. Quite recently, studies have identified some miRNAs operating to promote or suppress tumor invasion or metastasis via regulating metastasis-related genes, providing potential therapeutic targets on antimetastasis strategy. In this study, we found that the expression of RKIP and miR-98 in glioma tissues were significantly lower than that in normal brain tissues. Overexpression of RKIP upregulated miR-98 expression and inhibited glioma cell invasion and miR-98 target gene HMGA2 but had no effect in glioma cell proliferation. Moreover, forced expression of miR-98 accelerated the inhibition of glioma cell invasion and the expression of HMGA2 also had no effect in glioma cell proliferation. Our findings newly described RKIP/miR-98 to HMGA2 link and provided a potential mechanism for glioma cell invasion. RKIP and miR-98 may illustrate the potential therapeutic utility of signaling pathway signatures.

Indexed as

Cell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGliomaHMGA2 ProteinHumansMicroRNAsNeoplasm InvasivenessPhosphatidylethanolamine Binding ProteinSignal TransductionHMGA2 ProteinMicroRNAsMIRN98 microRNA, humanPEBP1 protein, humanPhosphatidylethanolamine Binding Protein

Identifiers

PMID24392454
PMCPMC3874320
OpenAlexW2097048673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.